Insights That Keep You Ahead
Our blog delivers clear updates on privacy, advertising, and compliance trends in digital marketing. From legal developments to practical strategies, we help marketers, advertisers, and publishers stay informed and prepared.
Has enforcement of CCPA been delayed for a year?
By: Linda L. Goodman You may have read headlines that claim enforcement of CCPA is delayed for a year – this is not completely accurate. In 2020, California voters approved the California Privacy Rights Act of 2020 (“CPRA”) which significantly
Does the California Privacy Protection Agency have to follow the law?
By: Linda L. Goodman The California Privacy Protection Agency’s (“Agency”) long-waited regulations to guide enforcement of the California Consumer Privacy Act (“CPRA”) were approved by the California Office of Administrative Law on March 31, 2023. These regulations were mandated by
Class Action Settlement … for CCPA?
By: Linda L. Goodman The California Consumer Privacy Act (“CCPA”) went into effect on January 1, 2020, with no private right of action – the only person who could bring suit was a government enforcement agency. In other words, the
Colorado Passes its Own Version of CCPA
By: Linda L. Goodman On June 9, 2021, Colorado passed the “Protect Personal Data Privacy” bill and sent the bill to the governor for signature. This makes Colorado the third state to pass legislation concerning additional protection of data relating
COVID Marketing Remains High Risk for ALL Products….
By: Linda L. Goodman On November 12th, the Federal Trade Commission (“FTC”) announced it had sent letters warning 20 more marketers nationwide to stop making unsubstantiated claims that their products and therapies can prevent or treat COVID-19, the disease allegedly
FTC Approves Consent Order with Marketer of Product Claiming to Prevent or Treat COVID-19 – Notice Anything Missing????
By: Linda L. Goodman The Federal Trade Commission (“FTC”) approved a final administrative consent order settling charges that a California-based marketer of a supplement called Thrive, which the FTC claimed consists mainly of Vitamin C and herbal extracts, made baseless
